Therefore, for patients with liver cirrhosis negative for HBsAg, whether they have anti-HBc or anti-HBs, HBV DNA should be observed to rule out OBI and allow timely treatment to prevent HCC. This evidence concerns the gene KRT88P and cirrhosis of liver.